Backlash to massive drug price slash for items on appeal.

Published: 2001-09-24 06:57:00

Updated: 2001-09-24 06:57:00

The drug industry sharply resists against the government's massive price slashes particularly for the items that earlier raised appeals, claiming that the government decision was measured without paying any consideration to the real market practice, and therefore the industry said they would take...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK